NovoCure Ltd — Director's Dealing 2018

Jun 15, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2018-06-13

Reporting Person: Kirson Eilon D. (Chief Science Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-06-13	Ordinary Shares	M	30750	$14.37	Acquired	70332	Direct
2018-06-13	Ordinary Shares	M	37500	$11.46	Acquired	107832	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-13	Options to Buy Ordinary Shares	$14.37	M	30750	Acquired	2025-02-23	Ordinary Shares (30750)	Direct
2018-06-13	Options to Buy Ordinary Shares	$11.46	M	37500	Acquired	2026-02-24	Ordinary Shares (37500)	Direct

Footnotes

F1: Options exercised were fully vested as of the date hereof.